Bridgewater Associates LP Reduces Holdings in Teladoc Health, Inc. (NYSE:TDOC)

Bridgewater Associates LP lowered its position in shares of Teladoc Health, Inc. (NYSE:TDOC) by 52.3% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 112,806 shares of the health services provider’s stock after selling 123,580 shares during the period. Bridgewater Associates LP owned approximately 0.07% of Teladoc Health worth $1,036,000 as of its most recent SEC filing.

A number of other hedge funds also recently made changes to their positions in TDOC. Signaturefd LLC raised its stake in shares of Teladoc Health by 148.7% during the second quarter. Signaturefd LLC now owns 2,868 shares of the health services provider’s stock valued at $28,000 after purchasing an additional 1,715 shares during the period. International Assets Investment Management LLC purchased a new stake in shares of Teladoc Health during the second quarter valued at approximately $29,000. Blue Trust Inc. increased its stake in shares of Teladoc Health by 84.5% in the third quarter. Blue Trust Inc. now owns 4,048 shares of the health services provider’s stock worth $40,000 after buying an additional 1,854 shares during the last quarter. Doheny Asset Management CA bought a new stake in shares of Teladoc Health in the second quarter worth $46,000. Finally, Benjamin F. Edwards & Company Inc. increased its stake in shares of Teladoc Health by 209.8% in the second quarter. Benjamin F. Edwards & Company Inc. now owns 5,015 shares of the health services provider’s stock worth $49,000 after buying an additional 3,396 shares during the last quarter. Hedge funds and other institutional investors own 76.82% of the company’s stock.

Teladoc Health Stock Performance

Shares of TDOC opened at $11.98 on Monday. The company has a market cap of $2.06 billion, a price-to-earnings ratio of -2.08 and a beta of 0.90. The firm has a fifty day moving average of $9.38 and a 200-day moving average of $9.25. Teladoc Health, Inc. has a 1 year low of $6.76 and a 1 year high of $22.54. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.69 and a current ratio of 1.73.

Teladoc Health (NYSE:TDOC) last posted its quarterly earnings data on Wednesday, October 30th. The health services provider reported ($0.19) earnings per share for the quarter, topping the consensus estimate of ($0.29) by $0.10. The business had revenue of $640.51 million during the quarter, compared to the consensus estimate of $630.50 million. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. As a group, equities analysts anticipate that Teladoc Health, Inc. will post -1.16 earnings per share for the current year.

Analysts Set New Price Targets

A number of brokerages recently issued reports on TDOC. The Goldman Sachs Group began coverage on shares of Teladoc Health in a research note on Friday, November 15th. They issued a “buy” rating and a $14.00 price target for the company. Jefferies Financial Group lifted their price target on shares of Teladoc Health from $8.00 to $10.00 and gave the stock a “hold” rating in a research note on Tuesday, September 17th. Deutsche Bank Aktiengesellschaft lifted their price target on shares of Teladoc Health from $10.00 to $12.00 and gave the stock a “hold” rating in a research note on Friday, November 1st. Barclays lifted their price target on shares of Teladoc Health from $10.00 to $12.00 and gave the stock an “overweight” rating in a research note on Thursday, October 31st. Finally, Evercore ISI lifted their price target on shares of Teladoc Health from $8.00 to $9.00 and gave the stock an “in-line” rating in a research note on Tuesday, October 8th. Fourteen research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $12.08.

Insider Buying and Selling

In other Teladoc Health news, COO Michael Willem Waters sold 4,218 shares of the business’s stock in a transaction dated Tuesday, September 3rd. The stock was sold at an average price of $7.16, for a total transaction of $30,200.88. Following the sale, the chief operating officer now owns 78,309 shares in the company, valued at approximately $560,692.44. The trade was a 5.11 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Mala Murthy sold 8,750 shares of the business’s stock in a transaction dated Tuesday, September 3rd. The stock was sold at an average price of $7.16, for a total value of $62,650.00. Following the sale, the chief financial officer now owns 85,767 shares in the company, valued at approximately $614,091.72. The trade was a 9.26 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 20,051 shares of company stock valued at $143,565 over the last 90 days. 0.95% of the stock is currently owned by company insiders.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.